Invites Healthcare Co., Ltd. agreed to acquire Invites Genomics Co., Ltd. from Invites Biocore Co., Ltd. (XKON:A216400) for KRW 10 billion on May 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,440 KRW | +5.47% | +6.43% | +1.51% |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 53.35M | |
-27.95% | 9.96B | |
-6.65% | 3.03B | |
+31.24% | 3B | |
-14.73% | 2.18B | |
-14.79% | 1.76B | |
+68.09% | 1.42B | |
+22.58% | 794M | |
-2.18% | 756M | |
+3.18% | 305M |
- Stock Market
- Equities
- A216400 Stock
- News Invites Biocore Co., Ltd.
- Invites Healthcare Co., Ltd. agreed to acquire Invites Genomics Co., Ltd. from Invites Biocore Co., Ltd. for KRW 10 billion